Incidence of ischemic cardiovascular events in the maraviroc clinical development program
نویسندگان
چکیده
Purpose of the study Maraviroc (MVC), a CCR5 antagonist, does not appear to adversely affect serum lipids and may decrease LDL cholesterol in dyslipidemic subjects. The CCR5-del32 polymorphism, resulting in reduced (heterozygous) or absent (homozygous) CCR5 expression, is associated with reduced risk of cardiovascular disease. An early imbalance of cardiovascular adverse events was noted in the MVC phase 2b development program at 24 weeks. We investigated the longer term risk of cardiovascular events in MVC recipients in the development program. The D:A:D study and other cohorts have reported an incidence of 3.6/1000 PY for myocardial infarction (MI) among patients on HAART.
منابع مشابه
Evaluation of the Relationship between Hematological Indices and Cardiovascular Events in Isfahan Cohort Study
Background and Objective: Cardiovascular Disease (CVD) is the leading cause of death in developing countries. Inflammation significantly contributes to the process of atherosclerosis. Therefore, evaluating White Blood Cells (WBC) and platelet counts as markers of inflammatory as well as hematocrit as a marker of blood viscosity may predict coronary events. The present study aimed to evaluate th...
متن کاملEvaluation of delay in Primary PCI in golden time and its relationship with major adverse cardiac events
Background: In patients with ST-segment elevation myocardial infarction (STEMI), Primary percutaneous coronary intervention (PCI) is the preferred reperfusion therapy. Timely primary PCI is essential in improving the clinical outcomes of these patients. The aim of this study was to evaluate the factors affecting balloon delay in STEMI treated patients by primary PCI and its relationship with ma...
متن کاملEfficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice.
BACKGROUND CCR5 plays an important role in atherosclerosis and ischemic cardiovascular diseases, as well as in HIV replication and diffusion. HIV infection is characterized by a high burden of cardiovascular diseases, particularly in subjects exposed to ritonavir-boosted protease inhibitors. Maraviroc, a CCR5 antagonist antiretroviral drug, might provide benefit for patients with M-tropic HIV i...
متن کاملEfficacy of CCR5 Antagonist Maraviroc in Reducing the Early, Ritonavir Induced, Atherogenesis and the Advanced Plaque Progression in Mice Running title: Cipriani et al.; Maraviroc Prevents the RTV-induced Atherosclerosis
Background—CCR5 plays an important role in atherosclerosis and ischemic cardiovascular
متن کاملA Critique of Studies on The Combined Effect of Dust Storms and Meteorological elements on Cardiovascular, Cerebrovascular, and Respiratory Diseases
Brief policy The studies reviewed in this section are from PubMed, ISI, Science Direct, Google Scholar, and Scopus databases using the following keywords: dust storm, meteorological elements, temperature, heat wave, cold wave, relative humidity, wind blow, atmospheric pressure, cardiovascular diseases, respiratory diseases, cerebrovascular diseases, myocardial infarction (MI), stroke (CVA), l...
متن کامل